CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Immunotherapy biomarkers

Original research

CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes

Online download statistics by month:

Online download statistics by month: August 2021 to March 2024

	Abstract	Full	Pdf
Aug 2021	33	33	6
Sep 2021	646	652	214
Oct 2021	169	170	46
Nov 2021	205	207	51
Dec 2021	99	101	27
Jan 2022	78	81	39
Feb 2022	74	74	46
Mar 2022	67	68	28
Apr 2022	67	68	32
May 2022	75	78	37
Jun 2022	92	101	40
Jul 2022	66	66	34
Aug 2022	86	86	23
Sep 2022	103	107	35
Oct 2022	87	95	41
Nov 2022	153	157	32
Dec 2022	72	75	31
Jan 2023	43	48	29
Feb 2023	74	74	29
Mar 2023	52	53	26
Apr 2023	25	25	22
May 2023	31	32	15
Jun 2023	40	40	15
Jul 2023	37	37	23
Aug 2023	36	36	11
Sep 2023	21	21	10
Oct 2023	46	47	18
Nov 2023	31	31	22
Dec 2023	37	37	28
Jan 2024	50	51	28
Feb 2024	34	35	17
Mar 2024	48	49	17
Total	2777	2835	1072